[go: up one dir, main page]

MA26945A1 - Derives de phenoxybenzylamine nouveaux servant d'inhibiteurs selectifs de reabsorption de serotonine. - Google Patents

Derives de phenoxybenzylamine nouveaux servant d'inhibiteurs selectifs de reabsorption de serotonine.

Info

Publication number
MA26945A1
MA26945A1 MA27049A MA27049A MA26945A1 MA 26945 A1 MA26945 A1 MA 26945A1 MA 27049 A MA27049 A MA 27049A MA 27049 A MA27049 A MA 27049A MA 26945 A1 MA26945 A1 MA 26945A1
Authority
MA
Morocco
Prior art keywords
phenoxybenzylamine
derivatives
novel
selective serotonin
reabsorption inhibitors
Prior art date
Application number
MA27049A
Other languages
English (en)
Inventor
Mavis Diane Adam
Mark David Andrews
Mark Leonard Elliott
Geoffrey Edward Gymer
David Hepworth
Harry Ralph Howard Jr
Donald Stuart Middleton
Alan Stobie
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0021593A external-priority patent/GB0021593D0/en
Priority claimed from GB0107116A external-priority patent/GB0107116D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of MA26945A1 publication Critical patent/MA26945A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/39—Heterocyclic compounds having sulfur as a ring hetero atom having oxygen in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/74—Quinazolines; Hydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
    • C07D327/06—Six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Addiction (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MA27049A 2000-08-31 2003-02-21 Derives de phenoxybenzylamine nouveaux servant d'inhibiteurs selectifs de reabsorption de serotonine. MA26945A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0021593A GB0021593D0 (en) 2000-08-31 2000-08-31 Diphenyl ether compounds useful in therapy
GB0107116A GB0107116D0 (en) 2001-03-21 2001-03-21 Novel compounds

Publications (1)

Publication Number Publication Date
MA26945A1 true MA26945A1 (fr) 2004-12-20

Family

ID=26244953

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27049A MA26945A1 (fr) 2000-08-31 2003-02-21 Derives de phenoxybenzylamine nouveaux servant d'inhibiteurs selectifs de reabsorption de serotonine.

Country Status (32)

Country Link
EP (1) EP1313701A1 (fr)
JP (1) JP2004507523A (fr)
KR (1) KR20030029889A (fr)
CN (1) CN1449380A (fr)
AP (1) AP2001002265A0 (fr)
AR (1) AR031867A1 (fr)
AU (1) AU2001278650A1 (fr)
BG (1) BG107544A (fr)
BR (1) BR0113610A (fr)
CA (1) CA2420969A1 (fr)
CZ (1) CZ2003467A3 (fr)
DO (1) DOP2001000242A (fr)
DZ (1) DZ3414A1 (fr)
EA (1) EA200300206A1 (fr)
EE (1) EE200300084A (fr)
HN (1) HN2001000191A (fr)
HR (1) HRP20030141A2 (fr)
HU (1) HUP0303385A2 (fr)
IL (1) IL154343A0 (fr)
IS (1) IS6704A (fr)
MA (1) MA26945A1 (fr)
MX (1) MXPA03001848A (fr)
NO (1) NO20030842L (fr)
NZ (1) NZ523951A (fr)
OA (1) OA12372A (fr)
PA (1) PA8526701A1 (fr)
PE (1) PE20020346A1 (fr)
PL (1) PL360743A1 (fr)
SK (1) SK2012003A3 (fr)
TN (1) TNSN01131A1 (fr)
UY (1) UY26924A1 (fr)
WO (1) WO2002018333A1 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403597B1 (en) * 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US6436938B1 (en) * 2001-01-22 2002-08-20 Pfizer Inc. Combination treatment for depression
US20020107244A1 (en) * 2001-02-02 2002-08-08 Howard Harry R. Combination treatment for depression
US20020183306A1 (en) * 2001-05-30 2002-12-05 Pfizer Inc. Combination treatment for sleep disorders including sleep apnea
GB0318706D0 (en) * 2003-08-08 2003-09-10 Pfizer Ltd Selective serotonin reuptake inhibitors in the treatment of disease
WO2005080320A1 (fr) 2004-02-13 2005-09-01 Warner-Lambert Company Llc Modulateurs du recepteur d'androgene
CA2563291A1 (fr) 2004-04-13 2005-10-27 Warner-Lambert Company Llc Derives de 4-cyanophenoxy-alkylcarboxyle comme modulateurs androgenes
JP2007533726A (ja) 2004-04-22 2007-11-22 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー アンドロゲンモジュレーター
BRPI0513020A (pt) 2004-07-08 2008-04-22 Warner Lambert Co moduladores de andrÈgenio, seus usos, composição farmacêutica, formulação farmacêutica tópica e artigo de fabricação
US20090105349A1 (en) * 2004-08-18 2009-04-23 Warner-Lambert Company Llc Androgen modulators
MX2007002732A (es) * 2004-09-10 2007-04-24 Pfizer Prod Inc Ligandos de difenil eter terapeuticos.
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
WO2007010350A1 (fr) * 2005-07-19 2007-01-25 Pfizer Products Inc. Synthèse d’éthers diphényliques à usage thérapeutique
JP4887368B2 (ja) 2005-10-13 2012-02-29 スミスクライン ビーチャム コーポレーション 新規ヘテロ環化合物
EP1976495A2 (fr) * 2006-01-06 2008-10-08 Aarhus Universitet Composes agissant sur le transporteur de la serotonine
AU2007265240A1 (en) * 2006-06-29 2008-01-03 Janssen Pharmaceutica N.V. Substituted aminomethyl benzamide compounds
WO2008002817A1 (fr) * 2006-06-29 2008-01-03 Janssen Pharmaceutica N.V. Composés butyle et butynyle benzyle amine
EP2049473A2 (fr) * 2006-06-29 2009-04-22 Janssen Pharmaceutica N.V. Composés de benzylamine substituée
US8642583B2 (en) 2008-10-30 2014-02-04 Janssen Pharmaceutica Nv Serotonin receptor modulators
US8575364B2 (en) 2008-10-30 2013-11-05 Janssen Pharmaceutica Nv Modulators of serotonin receptor
KR101043200B1 (ko) * 2010-11-08 2011-06-21 성시민 호흡용 공기탱크의 공기 충전장치
US9092242B2 (en) 2011-01-27 2015-07-28 Hewlett-Packard Development Company, L.P. Computing device to connect to a portable device
EP3936192B1 (fr) 2019-03-06 2025-04-09 Daiichi Sankyo Company, Limited Dérivé de pyrrolopyrazole

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA923283B (en) * 1991-05-29 1993-01-27 Akzo Nv Phenoxyphenyl derivatives
WO1995005376A1 (fr) * 1993-08-19 1995-02-23 Warner-Lambert Company Derives de 2(5h)furanone, 2(5h)thiophenone et 2(5h)pyrrolone substitues, leur preparation et leur utilisation en tant qu'antagonistes de l'endotheline
CZ293595A3 (cs) * 1995-11-09 1999-12-15 Farmak A. S. Deriváty N,N-dimethyl-2-(arylthio)benzylaminu, jejich soli, způsoby jejich přípravy a jejich použití v léčivých přípravcích
WO1999047497A2 (fr) * 1998-03-13 1999-09-23 Merck Frosst Canada & Co. Acides carboxyliques et acylsulfonamides, compositions contenant ces composes et methodes de traitement
WO2000050380A1 (fr) * 1999-02-23 2000-08-31 Pfizer Products Inc. Inhibiteurs de recaptage de monoamine destines au traitement de troubles du systeme nerveux central
GB0007884D0 (en) * 2000-03-31 2000-05-17 Pfizer Ltd Diphenyl ether compounds useful in therapy

Also Published As

Publication number Publication date
PE20020346A1 (es) 2002-05-08
PA8526701A1 (es) 2003-07-28
SK2012003A3 (en) 2004-06-08
DZ3414A1 (fr) 2002-03-07
HRP20030141A2 (en) 2003-04-30
CZ2003467A3 (cs) 2004-04-14
IS6704A (is) 2003-01-30
AR031867A1 (es) 2003-10-08
DOP2001000242A (es) 2002-05-15
EA200300206A1 (ru) 2003-06-26
BR0113610A (pt) 2003-06-24
AP2001002265A0 (en) 2001-09-30
HN2001000191A (es) 2002-03-11
MXPA03001848A (es) 2003-06-04
WO2002018333A1 (fr) 2002-03-07
PL360743A1 (en) 2004-09-20
HUP0303385A2 (hu) 2004-03-01
JP2004507523A (ja) 2004-03-11
BG107544A (bg) 2003-10-31
TNSN01131A1 (fr) 2005-11-10
NZ523951A (en) 2004-09-24
OA12372A (en) 2006-04-17
CA2420969A1 (fr) 2002-03-07
NO20030842L (no) 2003-04-28
IL154343A0 (en) 2003-09-17
EE200300084A (et) 2005-02-15
UY26924A1 (es) 2002-03-22
CN1449380A (zh) 2003-10-15
EP1313701A1 (fr) 2003-05-28
KR20030029889A (ko) 2003-04-16
AU2001278650A1 (en) 2002-03-13
NO20030842D0 (no) 2003-02-24

Similar Documents

Publication Publication Date Title
MA26945A1 (fr) Derives de phenoxybenzylamine nouveaux servant d'inhibiteurs selectifs de reabsorption de serotonine.
FR12C0007I2 (fr) Nouveaux derives de phenyle-propargylether
MA26887A1 (fr) Derives de piperazine nouveaux.
DE60216115D1 (de) BENZIMIDAZO 4,5-föISOCHINOLINON-DERIVATE
MXPA03008807A (es) Derivados de ciclopropilindol como inhibidores selectivos de recaptacion de serotonina.
EG25095A (en) Phenyl-piperazines derivatives as serotonin reuptake inhibitors.
DE60019577D1 (de) 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
DZ3439A1 (fr) Derives de 2-aminocarbonyl-9h-purine
DE60214428D1 (de) 1, 4-dihydro-1, 4-diphenylpyridin-derivate
MA26848A1 (fr) Derives d'heterocyclo-alkylsufonylpyrazole nouveaux servant d'agents anti-inflammatoires/analgesiques.
FR2838123B1 (fr) Nouveaux derives d'indolozine-1,2,3 substituee, inhibiteurs selectifs du b-fgf
IT1320509B1 (it) Faro per motociclo.
ATE414056T1 (de) Substituierte c-cyclohexylmethylamin-derivative
PT1104762E (pt) Imidazo¬1,2a|azinas substituidas como inibidoras selectivas de cox 2
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
AR028248A1 (es) Nuevos compuestos 2,3,4,5-tetrahidro-1h-(1,4) diazepino (1,7-a) indol
DZ3119A1 (fr) Nouveaux dérivés de n-triazolylmethyl-piperazines comme antagonistes des recepteurs de la neurokinine.
AR028607A1 (es) Derivados de 1,4-diazepan-2,5-diona
ATE282021T1 (de) Substituierte aminomethyl-phenyl- cyclohexanderivate
MA26941A1 (fr) Nouveaux derives d'aminocyclohexane
ATE272045T1 (de) Substituierte 1-aminobutan-3-ol-derivate
NO20042980L (no) 3,4-dihydro-1H-isokinolin-2-yl-derivater
FR2824826B1 (fr) Nouveaux derives de 5-cyano-1h-indole antagonistes des recepteurs de l'interleukine-8
NO20025475L (no) Nye benzotiofenderivater
ATE361274T1 (de) Substituierte 5-amino-1-penten-3-ol-derivate